Talicia
AssetAlso called omeprazole, amoxicillin, and rifabutin
- Stage
- Approved
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Approved by the FDA on Nov 1, 2019 (NDA213004). FDA
Indications
1Helicobacter pylori infection
Approved, FDA
In the full profile
- Owner and partners1
- Competitors5
Every asset’s record: target, stage, trials and the evidence behind it.